Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO: Baxdrostat in Uncontrolled Hypertension
NCT05137002Phase 2Completed
- Sponsor
- CinCor Pharma
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baxdrostat in hypertension (HTN), sponsored by CinCor Pharma. Started Dec 2021; status: completed.
02
Drugs
baxdrostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05137002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05137002.